| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1241941 | Talanta | 2015 | 7 Pages |
•The determination method of pyraoxystrobin in rat tissue was validated.•Tissue distribution of pyraoxystrobin in rat was investigated for the first time.•Individual difference existed in rat after oral administration of pyraoxystrobin.•The disproportion increase of AUC showed clear evidence of non-linear kinetics.
A simple, specific and reproducible liquid chromatography–tandem mass spectrometry (LC-MS/MS) method was developed for the determination of pyraoxystrobin in rat plasma and tissues. Chromatographic separation was achieved on a Zorbax Extend-C18 column (50×2.1 mm I. D., 3.5 µm), using a gradient mobile phase consisting of acetonitrile and 0.1% aqueous formic acid (v/v) at a flow rate of 0.5 mL min−1. Pyraoxystrobin and picoxystrobin (internal standard) were detected without interference in the selected reaction monitoring (SRM) mode with positive electrospray ionization. Further, the method was validated following FDA guideline. The calibration curves for plasma and tissues were linear over a concentration range of 1.00–200 ng mL−1, with lower limits of quantitation of 1.00 ng mL−1. Mean extraction recoveries in plasma and tissues ranged from 101.4% to 108.2% and from 49.1% to 59.4%, respectively. The intra-day and inter-day precision in plasma and tissues were within 9.9% and 8.9%, and the intra-day and inter-day accuracy ranged from 88.7% to 110.7% and 93.2% to 108.7%, respectively. Finally, the validated method was successfully applied to toxicokinetics and tissue distribution studies after oral administration of pyraoxystrobin to rats.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
